Trp53 regulates platelets in bone marrow via the PI3K pathway

Yang, Mingming; Liu, Qing; Niu, Ting; Kuang, Jianbiao; Zhang, Xiaohan; Jiang, Lingbi; Li, Siqi; He, Xiaodong; Wang, Lijing; Li, Jiangchao

doi:10.3892/etm.2020.8850

Cited by 3 publications

(2 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These seemingly contradictory findings are likely explained by the observation that thrombocytes can be generated by direct differentiation of HSCs into megakaryocytes without proliferation (Morcos, Li et al 2020), while maintenance of all other mature blood cells heavily relies on cell division of stem and progenitors cells. Interestingly, the thrombocythemia of RH2 hKO mice was reversed by loss of p53, in line with reported roles for p53 signaling in megakaryocyte endoreplication and thrombopoiesis (Apostolidis, Woulfe et al 2012, Yang, Liu et al 2020).…”

Section: Discussionsupporting

confidence: 86%

“…Similar observations were made in neurons (Aditi et al, 2021), skin (Hiller et al, 2018) and gut (Aden et al, 2019) epithelium. Interestingly, the thrombocythemia of RH2 hKO mice was reversed by loss of p53, in line with reported roles for p53 signaling in regulating megakaryocyte endoreplication and platelet numbers (Apostolidis et al, 2012; Yang et al, 2020).…”

Section: Discussionsupporting

confidence: 85%

See 1 more Smart Citation

Clearance of genome-damaged cells from the hematopoietic system via p53 without contribution by the cGAS/STING axis

Dressel

Natusch

Munz

et al. 2022

Preprint

View full text Add to dashboard Cite

Cell-intrinsic response patterns control risks arising from genome-damaged cells, preventing malignant transformation. p53-dependent DNA damage responses halt the cell cycle and induce either repair, senescence or cell death. Cyclic-GMP-AMP synthase (cGAS) has emerged as a new principle detecting genome damage and activating complex response programs. This DNA sensor is activated by micronuclei, chromosome bridges and prolonged mitotic arrest. STING-responses downstream of cGAS can drive cells into senescence or cell death through the induction of antiproliferative type I interferons (IFN) and proapoptotic tumor necrosis factor. Herein, we investigated how DNA damage-dependent and DNA-damage independent chronic activation of cGAS/STING signaling impacts on hematopoiesis. Hematopoietic loss of ribonucleotide excision repair (RER) resulted in chromosomal instability and activation of the cGAS/STING/IFN axis. Mice with hematopoietic RER-deficiency displayed compromised hematopoietic stem cell (HSC) function resulting in cytopenia and ultimately developed leukemia. Additional loss of p53 largely rescued mature blood cell production at the cost of accelerated leukemogenesis, while concurrent loss of cGAS, STING or type I IFN signalling had no detectable effect on HSC function, cytopenia and leukemia development in RER-deficient hematopoiesis. Also in models of acute genome damage, cGAS was irrelevant for the initial cell loss as well as the subsequent recovery of hematopoiesis. In contrast, a constitutive STING gain-of-function mutation impaired HSC functions independently of DNA damage. Collectively, we present in vivo evidence that the cGAS/STING pathway does not influence the capacity of the hematopoietic system to cope with DNA damage. Nevertheless, chronic activation of STING dramatically reduced the fitness of HSCs.

show abstract

Section: Discussionsupporting

confidence: 86%

Section: Discussionsupporting

confidence: 85%

Clearance of genome-damaged cells from the hematopoietic system via p53 without contribution by the cGAS/STING axis

Dressel

Natusch

Munz

et al. 2022

Preprint

View full text Add to dashboard Cite

show abstract

Overall survival in TP53-mutated AML and MDS

Puzo,

Hager,

Rinder

et al. 2024

Ann Hematol

View full text Add to dashboard Cite

Activation of the cGAS/STING Axis in Genome-Damaged Hematopoietic Cells Does Not Impact Blood Cell Formation or Leukemogenesis

et al. 2023

View full text Add to dashboard Cite

Genome damage is a main driver of malignant transformation, but it also induces aberrant inflammation via the cGAS/STING DNA sensing pathway. Activation of cGAS/STING can trigger cell death and senescence, thereby potentially eliminating genome-damaged cells and preventing against malignant transformation. Here, we report that defective ribonucleotide excision repair (RER) in the hematopoietic system caused genome instability with concomitant activation of the cGAS/STING axis and compromised hematopoietic stem cell function, ultimately resulting in leukemogenesis. Additional inactivation of cGAS, STING, or type I IFN signaling, however, had no detectable effect on blood cell generation and leukemia development in RER-deficient hematopoietic cells. In wild-type mice, hematopoiesis under steady-state conditions and in response to genome damage was not affected by loss of cGAS. Together, this data challenges a role of the cGAS/STING pathway in protecting the hematopoietic system against DNA damage and leukemic transformation.

show abstract

Trp53 regulates platelets in bone marrow via the PI3K pathway

Cited by 3 publications

References 31 publications

Clearance of genome-damaged cells from the hematopoietic system via p53 without contribution by the cGAS/STING axis

Clearance of genome-damaged cells from the hematopoietic system via p53 without contribution by the cGAS/STING axis

Overall survival in TP53-mutated AML and MDS

Activation of the cGAS/STING Axis in Genome-Damaged Hematopoietic Cells Does Not Impact Blood Cell Formation or Leukemogenesis

Contact Info

Product

Resources

About